Product Information
BETAMETHASONE SP-AC 30 MG/5 ML is a generic product labeled by American Regent, Inc., priced at $9.1383 per ML under NDC 00517072001. Its NADAC has been published 624 times since Nov 28, 2013.
FDA first approved this application on Jul 31, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3; 3 mg/mL; mg/mL
Manufacturer
American Regent, Inc.NDC
00517072001
Classification
Generic
Dosage Form
INJECTION, SUSPENSION
Route
INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA090747FDA Approved
7/31/2009
TE Code
AB
On Market Since
4/28/2010
Pharmacological Classes
Price Statistics
The NADAC for BETAMETHASONE SP-AC 30 MG/5 ML has been published 624 times since Nov 28, 2013, and over the history we have for it it has risen 59.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.1383 per ML |
|---|---|
| All-time high | $9.4699 (Oct 15, 2025) |
| All-time low | $5.7463 (Nov 28, 2013) |
| 52-week high | $9.4699 |
| 52-week low | $9.1383 |
| Median price | $8.1356 |
| Average price | $7.7338 |
| Largest weekly change | +33.2% (Jun 21, 2017) |
| Weeks tracked | 624 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Regent, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Betamethasone Sodium Phosphate and Betamethasone Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BETAMETHASONE SP-AC 30 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for BETAMETHASONE SP-AC 30 MG/5 ML, manufactured by American Regent, Inc., is $9.1383 per ML (NDC 00517072001), effective Sep 30, 2026.
How has the price of BETAMETHASONE SP-AC 30 MG/5 ML changed over time?
Over the history we have for it, the NADAC for BETAMETHASONE SP-AC 30 MG/5 ML has risen 59.0%. It has been tracked across 624 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BETAMETHASONE SP-AC 30 MG/5 ML?
Since Nov 28, 2013, the NADAC for BETAMETHASONE SP-AC 30 MG/5 ML has ranged from a low of $5.7463 (Nov 28, 2013) to a high of $9.4699 (Oct 15, 2025), with a median of $8.1356 per ML.
Are there cheaper alternatives to BETAMETHASONE SP-AC 30 MG/5 ML?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BETAMETHASONE SP-AC 30 MG/5 ML in a comparable dosage form, but none are currently priced below it.
Who manufactures BETAMETHASONE SP-AC 30 MG/5 ML?
BETAMETHASONE SP-AC 30 MG/5 ML (NDC 00517072001) is labeled by American Regent, Inc., and CMS classifies it as a generic product.